Published in J Am Geriatr Soc on April 01, 2009
Treatment with cholinesterase inhibitors and memantine of patients in the Alzheimer's Disease Neuroimaging Initiative. Arch Neurol (2011) 1.75
Potentially inappropriate medication use in older adults with mild cognitive impairment. J Gerontol A Biol Sci Med Sci (2009) 1.01
Mild cognitive impairment in clinical care: a survey of American Academy of Neurology members. Neurology (2010) 1.00
Walking stabilizes cognitive functioning in Alzheimer's disease (AD) across one year. Arch Gerontol Geriatr (2012) 0.95
Donepezil treatment in ethnically diverse patients with Alzheimer disease. Am J Geriatr Psychiatry (2014) 0.75
"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res (1975) 301.74
Mild cognitive impairment: clinical characterization and outcome. Arch Neurol (1999) 33.06
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet (2002) 17.19
Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med (2005) 12.04
Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Arch Neurol (2000) 8.07
A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. N Engl J Med (1997) 7.56
Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA (2005) 7.35
High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial. JAMA (2008) 7.35
Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology (1992) 5.95
Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 1. Arch Neurol (2003) 4.82
Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study. Lancet Neurol (2007) 3.22
Clinical criteria for the diagnosis of vascular dementia: a multicenter study of comparability and interrater reliability. Arch Neurol (2000) 3.05
Safety and efficacy of galantamine in subjects with mild cognitive impairment. Neurology (2008) 2.79
Subtype of mild cognitive impairment and progression to dementia and death. Dement Geriatr Cogn Disord (2006) 2.01
Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results. Arch Neurol (2005) 1.98
Lipid lowering agents are associated with a slower cognitive decline in Alzheimer's disease. J Neurol Neurosurg Psychiatry (2005) 1.81
American Psychiatric Association practice guideline for the treatment of patients with Alzheimer's disease and other dementias. Second edition. Am J Psychiatry (2007) 1.79
Donepezil treatment and Alzheimer disease: can the results of randomized clinical trials be applied to Alzheimer disease patients in clinical practice? Am J Geriatr Psychiatry (2007) 1.57
Impact of antioxidants, zinc, and copper on cognition in the elderly: a randomized, controlled trial. Neurology (2004) 1.49
Homocysteine, vitamin B-12, and folic acid and the risk of cognitive decline in old age: the Leiden 85-Plus study. Am J Clin Nutr (2005) 1.20
Blessed-Roth Dementia Scale (DS). Psychopharmacol Bull (1988) 1.20
Randomized controlled trial of homocysteine-lowering vitamin treatment in elderly patients with vascular disease. Am J Clin Nutr (2005) 1.17
Hyperhomocysteinemia associated with poor recall in the third National Health and Nutrition Examination Survey. Am J Clin Nutr (2001) 1.06
Statin therapy in Alzheimer's disease. Acta Neurol Scand Suppl (2006) 0.99
Plasma folate concentration and cognitive performance: Rotterdam Scan Study. Am J Clin Nutr (2007) 0.95
Statins for the prevention of Alzheimer's disease. Cochrane Database Syst Rev (2001) 0.91
Treating the full spectrum of dementia with memantine. Int J Geriatr Psychiatry (2003) 0.81
Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 24.02
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain (2011) 9.90
The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol (2011) 8.15
Functional status of elderly adults before and after initiation of dialysis. N Engl J Med (2009) 6.45
Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence. JAMA (2005) 6.20
Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA (2009) 5.75
Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study. BMJ (2005) 5.34
Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease: a meta-analysis. JAMA (2003) 5.23
The NIH Cognitive and Emotional Health Project. Report of the Critical Evaluation Study Committee. Alzheimers Dement (2006) 5.05
Hearing loss and cognitive decline in older adults. JAMA Intern Med (2013) 4.25
Kidney function and cognitive impairment in US adults: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Am J Kidney Dis (2008) 3.87
Divergent network connectivity changes in behavioural variant frontotemporal dementia and Alzheimer's disease. Brain (2010) 3.84
Depressive symptoms, vascular disease, and mild cognitive impairment: findings from the Cardiovascular Health Study. Arch Gen Psychiatry (2006) 3.61
Cognitive function, gait speed decline, and comorbidities: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci (2007) 3.61
A cognitive training program based on principles of brain plasticity: results from the Improvement in Memory with Plasticity-based Adaptive Cognitive Training (IMPACT) study. J Am Geriatr Soc (2009) 3.58
Limited literacy and mortality in the elderly: the health, aging, and body composition study. J Gen Intern Med (2006) 3.51
Use of antidepressants and rates of hip bone loss in older women: the study of osteoporotic fractures. Arch Intern Med (2007) 3.50
Position statement of the American Association for Geriatric Psychiatry regarding principles of care for patients with dementia resulting from Alzheimer disease. Am J Geriatr Psychiatry (2006) 3.22
Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease. Arch Neurol (2003) 3.20
Chronic kidney disease and cognitive impairment in the elderly: the health, aging, and body composition study. J Am Soc Nephrol (2005) 3.14
Patient and caregiver characteristics associated with depression in caregivers of patients with dementia. J Gen Intern Med (2003) 3.13
A longitudinal study of cardiorespiratory fitness and cognitive function in healthy older adults. J Am Geriatr Soc (2003) 3.09
Predicting regional neurodegeneration from the healthy brain functional connectome. Neuron (2012) 3.07
Frontal paralimbic network atrophy in very mild behavioral variant frontotemporal dementia. Arch Neurol (2008) 3.03
The association between physical function and lifestyle activity and exercise in the health, aging and body composition study. J Am Geriatr Soc (2004) 2.93
Additive effects of cognitive function and depressive symptoms on mortality in elderly community-living adults. J Gerontol A Biol Sci Med Sci (2003) 2.82
Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension: results from the Cardiovascular Health Study. Arch Intern Med (2009) 2.82
Fresh blood and aged stored blood are equally efficacious in immediately reversing anemia-induced brain oxygenation deficits in humans. Anesthesiology (2006) 2.79
Inflammatory markers and depressed mood in older persons: results from the Health, Aging and Body Composition study. Biol Psychiatry (2003) 2.77
Poor sleep is associated with impaired cognitive function in older women: the study of osteoporotic fractures. J Gerontol A Biol Sci Med Sci (2006) 2.73
Different regional patterns of cortical thinning in Alzheimer's disease and frontotemporal dementia. Brain (2007) 2.72
Neuropathological basis of magnetic resonance images in aging and dementia. Ann Neurol (2008) 2.71
Contribution of Alzheimer disease to mortality in the United States. Neurology (2014) 2.67
Cognitive impact of subcortical vascular and Alzheimer's disease pathology. Ann Neurol (2006) 2.62
Training the next generation of research mentors: the University of California, San Francisco, Clinical & Translational Science Institute Mentor Development Program. Clin Transl Sci (2009) 2.60
Cognitive impairment in chronic kidney disease. J Am Geriatr Soc (2004) 2.50
Circadian activity rhythms and risk of incident dementia and mild cognitive impairment in older women. Ann Neurol (2011) 2.46
High occurrence of mood and anxiety disorders among older adults: The National Comorbidity Survey Replication. Arch Gen Psychiatry (2010) 2.43
Diagnostic criteria for the behavioral variant of frontotemporal dementia (bvFTD): current limitations and future directions. Alzheimer Dis Assoc Disord (2007) 2.43
Association between physical and cognitive function in healthy elderly: the health, aging and body composition study. Neuroepidemiology (2005) 2.39
Depression and risk of developing dementia. Nat Rev Neurol (2011) 2.31
Adverse oral health and cognitive decline: the health, aging and body composition study. J Am Geriatr Soc (2013) 2.27
Body mass index in midlife and risk of Alzheimer disease and vascular dementia. Curr Alzheimer Res (2007) 2.19
Promising strategies for the prevention of dementia. Arch Neurol (2009) 2.14
Psychometrically matched measures of global cognition, memory, and executive function for assessment of cognitive decline in older persons. Neuropsychology (2003) 2.11
ACNP White Paper: update on use of antipsychotic drugs in elderly persons with dementia. Neuropsychopharmacology (2007) 2.09
White matter damage in frontotemporal dementia and Alzheimer's disease measured by diffusion MRI. Brain (2009) 2.08
Activity energy expenditure and incident cognitive impairment in older adults. Arch Intern Med (2011) 2.07
Limited literacy in older people and disparities in health and healthcare access. J Am Geriatr Soc (2006) 2.06
The Mental Activity and eXercise (MAX) trial: a randomized controlled trial to enhance cognitive function in older adults. JAMA Intern Med (2013) 2.05
Effect of postmenopausal hormone therapy on cognitive function: the Heart and Estrogen/progestin Replacement Study. Am J Med (2002) 2.02
Executive function, more than global cognition, predicts functional decline and mortality in elderly women. J Gerontol A Biol Sci Med Sci (2007) 1.97
Reliability and validity of the Delis-Kaplan Executive Function System: an update. J Int Neuropsychol Soc (2004) 1.96
Relationship between vitamin B12 and sensory and motor peripheral nerve function in older adults. J Am Geriatr Soc (2012) 1.96
Change in cognitive function by glucose tolerance status in older adults: a 4-year prospective study of the Rancho Bernardo study cohort. Arch Intern Med (2004) 1.95
Circulating 25-hydroxyvitamin D levels and frailty status in older women. J Clin Endocrinol Metab (2010) 1.93
Chronic kidney disease and cognitive impairment in menopausal women. Am J Kidney Dis (2005) 1.91
Vision impairment and combined vision and hearing impairment predict cognitive and functional decline in older women. J Am Geriatr Soc (2004) 1.88
Depressive symptoms in middle age and the development of later-life functional limitations: the long-term effect of depressive symptoms. J Am Geriatr Soc (2010) 1.88
Memantine in patients with frontotemporal lobar degeneration: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol (2013) 1.84
Age effects on atrophy rates of entorhinal cortex and hippocampus. Neurobiol Aging (2005) 1.83
Development of methodology for conducting clinical trials in frontotemporal lobar degeneration. Brain (2008) 1.82
Continuum of frontal lobe impairment in amyotrophic lateral sclerosis. Arch Neurol (2007) 1.81
A meta-analysis of cortisol response to challenge in human aging: importance of gender. Psychoneuroendocrinology (2005) 1.79
Cumulative inflammatory load is associated with short leukocyte telomere length in the Health, Aging and Body Composition Study. PLoS One (2011) 1.78
Physical activity over the life course and its association with cognitive performance and impairment in old age. J Am Geriatr Soc (2010) 1.76
Cognitive impairment, depressive symptoms, and functional decline in older people. J Am Geriatr Soc (2002) 1.76
The last 2 years of life: functional trajectories of frail older people. J Am Geriatr Soc (2003) 1.74
TDP-43 frontotemporal lobar degeneration and autoimmune disease. J Neurol Neurosurg Psychiatry (2013) 1.74
Long-term cognitive and functional effects of potentially inappropriate medications in older women. J Gerontol A Biol Sci Med Sci (2013) 1.74
Profiles of neuropsychological impairment in autopsy-defined Alzheimer's disease and cerebrovascular disease. Brain (2007) 1.73
Depressive symptoms and change in abdominal obesity in older persons. Arch Gen Psychiatry (2008) 1.73
Diabetes mellitus, glycemic control, and incident depressive symptoms among 70- to 79-year-old persons: the health, aging, and body composition study. Arch Intern Med (2007) 1.73
Gait speed predicts decline in attention and psychomotor speed in older adults: the health aging and body composition study. Neuroepidemiology (2007) 1.68
Heightened emotional contagion in mild cognitive impairment and Alzheimer's disease is associated with temporal lobe degeneration. Proc Natl Acad Sci U S A (2013) 1.67
New insights into the dementia epidemic. N Engl J Med (2013) 1.67
Cognitive and neuroimaging predictors of instrumental activities of daily living. J Int Neuropsychol Soc (2007) 1.66
Perioperative cognitive decline in the aging population. Mayo Clin Proc (2011) 1.66
Dissociable executive functions in behavioral variant frontotemporal and Alzheimer dementias. Neurology (2013) 1.65
Longitudinal changes in memory and executive functioning are associated with longitudinal change in instrumental activities of daily living in older adults. Clin Neuropsychol (2008) 1.62
Contribution of metabolic syndrome components to cognition in older individuals. Diabetes Care (2007) 1.61
Serum leptin level and cognition in the elderly: Findings from the Health ABC Study. Neurobiol Aging (2008) 1.59
Donepezil treatment and Alzheimer disease: can the results of randomized clinical trials be applied to Alzheimer disease patients in clinical practice? Am J Geriatr Psychiatry (2007) 1.57
Depressed mood is not a risk factor for incident dementia in a community-based cohort. Am J Geriatr Psychiatry (2009) 1.54
Double dissociation of social functioning in frontotemporal dementia. Neurology (2003) 1.54
Midlife vs late-life depressive symptoms and risk of dementia: differential effects for Alzheimer disease and vascular dementia. Arch Gen Psychiatry (2012) 1.53
Neuropsychiatric symptoms in Alzheimer's disease: past progress and anticipation of the future. Alzheimers Dement (2013) 1.51
What explains differences between dementia patients' and their caregivers' ratings of patients' quality of life? Am J Geriatr Psychiatry (2004) 1.49
Kidney function and cognitive performance and decline in older men. J Am Geriatr Soc (2008) 1.48
Patterns of cognitive and emotional empathy in frontotemporal lobar degeneration. Cogn Behav Neurol (2005) 1.48
Association of sleep characteristics and cognition in older community-dwelling men: the MrOS sleep study. Sleep (2011) 1.48
One-year test-retest reliability of intrinsic connectivity network fMRI in older adults. Neuroimage (2012) 1.47
Dementia and cognitive impairment in ESRD: diagnostic and therapeutic strategies. Kidney Int (2010) 1.47
17q-linked frontotemporal dementia-amyotrophic lateral sclerosis without tau mutations with tau and alpha-synuclein inclusions. Arch Neurol (2004) 1.47
Black and white differences in cognitive function test scores: what explains the difference? J Am Geriatr Soc (2004) 1.47
Hippocampal atrophy patterns in mild cognitive impairment and Alzheimer's disease. Hum Brain Mapp (2010) 1.47
Socioeconomic differences in cognitive decline and the role of biomedical factors. Ann Epidemiol (2005) 1.45
Mild cognitive impairment, dementia, and their subtypes in oldest old women. Arch Neurol (2011) 1.45